Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Annexon, Inc. (ANNX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Annexon, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1528115.
Total stock buying since 2020: $54,919,964.
Total stock sales since 2020: $2,382,021.
Total stock option exercises since 2020: $715,594.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 12,345 | $28,721 | 22,467 | $64,990 | 37,994 | $53,571 |
| 2024 | 25,600 | $139,516 | 47,300 | $286,599 | 119,857 | $221,734 |
| 2023 | 3,297,058 | $19,647,594 | 33,159 | $163,733 | 21,000 | $34,230 |
| 2022 | 2,513,988 | $9,570,133 | 0 | $0 | 0 | $0 |
| 2021 | 0 | $0 | 74,962 | $1,866,699 | 175,904 | $406,059 |
| 2020 | 1,502,000 | $25,534,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-09 | 4,115 | $8,600 | 0 | $0 | 0 | $0 |
| 2025-07 | 4,115 | $9,999 | 3,086 | $7,986 | 0 | $0 |
| 2025-06 | 4,115 | $10,122 | 0 | $0 | 0 | $0 |
| 2025-02 | 0 | $0 | 19,381 | $57,004 | 0 | $0 |
| 2025-01 | 0 | $0 | 0 | $0 | 37,994 | $53,571 |
| 2024-12 | 3,200 | $17,056 | 0 | $0 | 0 | $0 |
| 2024-10 | 3,200 | $19,104 | 5,408 | $40,073 | 119,857 | $221,734 |
| 2024-09 | 3,200 | $17,536 | 15,500 | $96,850 | 0 | $0 |
| 2024-08 | 3,200 | $19,968 | 5,500 | $32,725 | 0 | $0 |
| 2024-07 | 3,200 | $16,000 | 2,994 | $18,034 | 0 | $0 |
| 2024-06 | 3,200 | $15,459 | 0 | $0 | 0 | $0 |
| 2024-05 | 3,200 | $14,982 | 0 | $0 | 0 | $0 |
| 2024-04 | 3,200 | $19,411 | 0 | $0 | 0 | $0 |
| 2024-02 | 0 | $0 | 17,898 | $98,917 | 0 | $0 |
| 2023-12 | 350,000 | $1,008,000 | 21,000 | $94,962 | 21,000 | $34,230 |
| 2023-07 | 0 | $0 | 2,035 | $7,805 | 0 | $0 |
| 2023-05 | 300,000 | $639,600 | 0 | $0 | 0 | $0 |
| 2023-02 | 2,647,058 | $17,999,994 | 10,124 | $60,966 | 0 | $0 |
| 2022-07 | 2,453,988 | $9,423,313 | 0 | $0 | 0 | $0 |
| 2022-04 | 60,000 | $146,820 | 0 | $0 | 0 | $0 |
| 2021-11 | 0 | $0 | 0 | $0 | 100,942 | $164,535 |
| 2021-09 | 0 | $0 | 27,190 | $559,236 | 27,190 | $89,565 |
| 2021-06 | 0 | $0 | 7,500 | $168,228 | 7,500 | $10,574 |
| 2021-04 | 0 | $0 | 500 | $14,050 | 500 | $705 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-02 | Carson William H. | Buy | 4,115 | 2.09 | 8,600 |
| 2025-07-30 | Carson William H. | Buy | 4,115 | 2.43 | 9,999 |
| 2025-07-14 | Yednock Ted (EVP & CHIEF INNOVATION OFFICER) | Sale | 1,116 | 2.58 | 2,879 |
| 2025-07-14 | Overdorf Michael (EVP & CHIEF BUSINESS OFFICER) | Sale | 853 | 2.61 | 2,226 |
| 2025-07-14 | Lew Jennifer (EVP & CHIEF FINANCIAL OFFICER) | Sale | 1,117 | 2.58 | 2,881 |
| 2025-06-30 | Carson William H. | Buy | 4,115 | 2.46 | 10,122 |
| 2025-02-18 | Artis Dean Richard (EVP & CHIEF SCIENTIFIC OFFICER) | Sale | 5,515 | 2.97 | 16,379 |
| 2025-02-18 | Yednock Ted (EVP & CHIEF INNOVATION OFFICER) | Sale | 8,345 | 2.91 | 24,283 |
| 2025-02-18 | Dananberg Jamie (CHIEF MEDICAL OFFICER) | Sale | 5,521 | 2.96 | 16,342 |
| 2025-01-06 | Love Douglas (PRESIDENT AND CEO) | Option Ex | 37,994 | 1.41 | 53,571 |
| 2024-12-02 | Carson William H. | Buy | 3,200 | 5.33 | 17,056 |
| 2024-10-30 | Love Douglas (PRESIDENT AND CEO) | Option Ex | 114,449 | 1.85 | 211,730 |
| 2024-10-15 | Yednock Ted (EVP & CHIEF INNOVATION OFFICER) | Sale | 5,408 | 7.41 | 40,073 |
| 2024-10-15 | Yednock Ted (EVP & CHIEF INNOVATION OFFICER) | Option Ex | 5,408 | 1.85 | 10,004 |
| 2024-10-01 | Carson William H. | Buy | 3,200 | 5.97 | 19,104 |
| 2024-09-19 | Yednock Ted (EVP & CHIEF INNOVATION OFFICER) | Sale | 4,500 | 7.10 | 31,950 |
| 2024-09-12 | Yednock Ted (EVP & CHIEF INNOVATION OFFICER) | Sale | 5,500 | 6.16 | 33,880 |
| 2024-09-05 | Yednock Ted (EVP & CHIEF INNOVATION OFFICER) | Sale | 5,500 | 5.64 | 31,020 |
| 2024-09-03 | Carson William H. | Buy | 3,200 | 5.48 | 17,536 |
| 2024-08-29 | Yednock Ted (EVP & CHIEF INNOVATION OFFICER) | Sale | 5,500 | 5.95 | 32,725 |
| 2024-08-01 | Carson William H. | Buy | 3,200 | 6.24 | 19,968 |
| 2024-07-15 | Yednock Ted (EVP & CHIEF INNOVATION OFFICER) | Sale | 1,106 | 6.02 | 6,658 |
| 2024-07-15 | Overdorf Michael (EVP & CHIEF BUSINESS OFFICER) | Sale | 784 | 6.02 | 4,719 |
| 2024-07-15 | Lew Jennifer (EVP & CHIEF FINANCIAL OFFICER) | Sale | 1,104 | 6.03 | 6,657 |
| 2024-07-01 | Carson William H. | Buy | 3,200 | 5.00 | 16,000 |
| 2024-06-03 | Carson William H. | Buy | 3,200 | 4.83 | 15,459 |
| 2024-05-01 | Carson William H. | Buy | 3,200 | 4.68 | 14,982 |
| 2024-04-08 | Carson William H. | Buy | 3,200 | 6.07 | 19,411 |
| 2024-02-20 | Yednock Ted (EVP & CHIEF INNOVATION OFFICER) | Sale | 2,604 | 5.51 | 14,348 |
| 2024-02-20 | Overdorf Michael (EVP & CHIEF BUSINESS OFFICER) | Sale | 1,951 | 5.48 | 10,691 |
| 2024-02-20 | Lew Jennifer (EVP & CHIEF FINANCIAL OFFICER) | Sale | 2,593 | 5.53 | 14,339 |
| 2024-02-12 | Yednock Ted (EVP & CHIEF INNOVATION OFFICER) | Sale | 1,810 | 5.54 | 10,027 |
| 2024-02-12 | Overdorf Michael (EVP & CHIEF BUSINESS OFFICER) | Sale | 1,349 | 5.53 | 7,459 |
| 2024-02-12 | Love Douglas (PRESIDENT AND CEO) | Sale | 5,782 | 5.54 | 32,032 |
| 2024-02-12 | Lew Jennifer (EVP & CHIEF FINANCIAL OFFICER) | Sale | 1,809 | 5.54 | 10,021 |
| 2023-12-27 | Yednock Ted (EVP & Chief Innovation Officer) | Sale | 21,000 | 4.52 | 94,962 |
| 2023-12-27 | Yednock Ted (EVP & Chief Innovation Officer) | Option Ex | 21,000 | 1.63 | 34,230 |
| 2023-12-26 | Satter Muneer A (Director) | Buy | 350,000 | 2.88 | 1,008,000 |
| 2023-07-11 | Overdorf Michael (EVP & Chief Business Officer) | Sale | 978 | 3.84 | 3,751 |
| 2023-07-11 | Lew Jennifer (EVP & Chief Financial Officer) | Sale | 1,057 | 3.84 | 4,054 |
| 2023-05-25 | Bcip Life Sciences Associates, Lp (10% Owner) | Buy | 300,000 | 2.13 | 639,600 |
| 2023-02-15 | Love Douglas (President & CEO) | Sale | 6,571 | 5.87 | 38,565 |
| 2023-02-14 | Overdorf Michael (EVP & Chief Business Officer) | Sale | 144 | 6.30 | 907 |
| 2023-02-14 | Lew Jennifer (EVP & Chief Financial Officer) | Sale | 166 | 6.30 | 1,046 |
| 2023-02-13 | Overdorf Michael (EVP & Chief Business Officer) | Sale | 1,501 | 6.30 | 9,460 |
| 2023-02-13 | Lew Jennifer (EVP & Chief Financial Officer) | Sale | 1,742 | 6.31 | 10,988 |
| 2023-02-10 | Satter Muneer A | Buy | 2,647,058 | 6.80 | 17,999,994 |
| 2022-07-07 | Satter Muneer A | Buy | 2,453,988 | 3.84 | 9,423,313 |
| 2022-04-14 | Love Douglas (President & CEO) | Buy | 60,000 | 2.45 | 146,820 |
| 2021-11-11 | Love Douglas (President & CEO) | Option Ex | 100,942 | 1.63 | 164,535 |
| 2021-09-16 | Love Douglas (President & CEO) | Sale | 7,500 | 22.05 | 165,337 |
| 2021-09-16 | Love Douglas (President & CEO) | Option Ex | 7,500 | 1.41 | 10,575 |
| 2021-09-13 | Yednock Ted (EVP & Chief Scientific Officer) | Sale | 16,190 | 20.00 | 323,864 |
| 2021-09-13 | Yednock Ted (EVP & Chief Scientific Officer) | Option Ex | 16,190 | 3.26 | 52,779 |
| 2021-09-13 | Lew Jennifer (EVP & Chief Financial Officer) | Sale | 3,500 | 20.01 | 70,035 |
| 2021-09-13 | Lew Jennifer (EVP & Chief Financial Officer) | Option Ex | 3,500 | 7.49 | 26,211 |
| 2021-06-08 | Love Douglas (President & CEO) | Sale | 3,750 | 22.55 | 84,562 |
| 2021-06-08 | Love Douglas (President & CEO) | Option Ex | 3,750 | 1.41 | 5,287 |
| 2021-06-07 | Love Douglas (President & CEO) | Sale | 3,750 | 22.31 | 83,666 |
| 2021-06-07 | Love Douglas (President & CEO) | Option Ex | 3,750 | 1.41 | 5,287 |
| 2021-04-01 | Love Douglas (President & CEO) | Sale | 500 | 28.10 | 14,050 |
| 2021-04-01 | Love Douglas (President & CEO) | Option Ex | 500 | 1.41 | 705 |
| 2021-03-31 | Love Douglas (President & CEO) | Sale | 7,102 | 28.11 | 199,623 |
| 2021-03-31 | Love Douglas (President & CEO) | Option Ex | 7,102 | 1.41 | 10,013 |
| 2021-03-30 | Love Douglas (President & CEO) | Sale | 3,750 | 24.53 | 91,980 |
| 2021-03-30 | Love Douglas (President & CEO) | Option Ex | 3,750 | 1.41 | 5,287 |
| 2021-03-29 | Love Douglas (President & CEO) | Sale | 3,750 | 26.23 | 98,347 |
| 2021-03-29 | Love Douglas (President & CEO) | Option Ex | 3,750 | 1.41 | 5,287 |
| 2021-03-25 | Yednock Ted (EVP & Chief Scientific Officer) | Sale | 16,175 | 29.24 | 472,892 |
| 2021-03-25 | Yednock Ted (EVP & Chief Scientific Officer) | Option Ex | 16,175 | 3.26 | 52,730 |
| 2021-03-24 | Keswani Sanjay (EVP & Chief Medical Officer) | Sale | 3,995 | 30.17 | 120,513 |
| 2021-03-24 | Keswani Sanjay (EVP & Chief Medical Officer) | Option Ex | 3,995 | 7.49 | 29,918 |
| 2021-03-23 | Lew Jennifer (EVP & Chief Financial Officer) | Sale | 5,000 | 28.37 | 141,830 |
| 2021-03-23 | Lew Jennifer (EVP & Chief Financial Officer) | Option Ex | 5,000 | 7.49 | 37,445 |
| 2020-07-28 | Schwartz Jeffrey Lawrence (10% Owner) | Buy | 400,000 | 17.00 | 6,800,000 |
| 2020-07-28 | Lew Jennifer (EVP & Chief Financial Officer) | Buy | 2,000 | 17.00 | 34,000 |
| 2020-07-28 | Satter Muneer A | Buy | 200,000 | 17.00 | 3,400,000 |
| 2020-07-28 | Deerfield Partners, L.p. | Buy | 700,000 | 17.00 | 11,900,000 |
| 2020-07-28 | Schwarzman Stephen A (10% Owner) | Buy | 200,000 | 17.00 | 3,400,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of ANNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Annexon, Inc. (symbol ANNX, CIK number 1528115) see the Securities and Exchange Commission (SEC) website.